Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2013-03-28 Regulatory Filings
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1876 characters) and is explicitly marked with an 'RNS Number' and states, 'In conformity with DTR 5.6.1R, the Company notifies the market of the following:'. It details the total number of issued shares with voting rights (87,095,524), which is a standard notification required under Disclosure and Transparency Rules (DTR). This type of mandatory, short regulatory update that doesn't fit a specific financial report category (like 10-K, ER, or IR) is best classified as a general Regulatory Filing (RNS). It is not a dividend announcement (DIV), director dealing (DIRS), or major shareholding notification (MRQ), as it is reporting the total outstanding shares denominator, not a change in a specific shareholder's stake or a transaction in own shares.
2013-03-28 English
Blocklisting Six Monthly Return
Share Issue/Capital Change Classification · 99% confidence The document is explicitly labeled as an 'RNS Number' and contains a 'BLOCK LISTING SIX MONTHLY RETURN' for Dechra Pharmaceuticals PLC, dated March 15, 2013. It details the status of unallotted securities under various share option schemes over a six-month period (Sept 2012 to Mar 2013). This type of routine regulatory filing, which reports on share movements and capital structure updates but is not a comprehensive annual report (10-K) or a specific dividend/insider trade notice, fits best under the general 'Regulatory Filings' category (RNS) as it is a standard notification provided to the market via the RNS service. While it relates to share capital, it is a periodic compliance return rather than a specific share issue announcement (SHA) or transaction report (POS).
2013-03-15 English
Director/PDMR Shareholding
Remuneration Information Classification · 100% confidence The document explicitly starts with an 'RNS Number' and is dated 05 March 2013. The content details shareholding changes involving Directors/PDMRs (Director/PDMR Shareholding) concerning the granting of options under a Long Term Incentive Plan. This directly corresponds to the definition of Director's Dealing (insider trades/transactions by executives). Therefore, the appropriate code is DIRS.
2013-03-05 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1882 characters) and explicitly states it is providing 'Additional information' under an 'RNS Number'. The content details the total number of issued shares with voting rights (87,072,727) as of the announcement date (28 February 2013) and references compliance with DTR 5.6.1R (Disclosure and Transparency Rules). This type of notification regarding the total voting rights denominator is a standard regulatory disclosure, often falling under general regulatory announcements or specific share/capital change notifications. Since it is a direct notification of a change in the total number of shares with voting rights, it aligns closely with 'Share Issue/Capital Change' (SHA) or, given the context of an RNS number and compliance disclosure, it could be a general 'Regulatory Filing' (RNS). However, the core information is about the total share capital count, which is a specific capital structure detail. Given the options, SHA covers changes in share capital, but this is a notification *about* the current total share capital for voting purposes, which is often categorized under general regulatory news if not explicitly a new issue or buyback. Since it is a direct notification published via RNS regarding share capital structure for transparency rules, RNS is the most appropriate general regulatory category if SHA is too specific for a simple count update, but SHA is also highly relevant. Let's re-evaluate the definitions. SHA is 'Announcement regarding new share issues, stock splits, or other capital changes.' This is a notification of the *current* total capital for voting purposes, not necessarily a change event itself, although it implies the current state resulting from past changes. Given the presence of 'RNS Number' and the nature of the disclosure (DTR compliance), RNS (Regulatory Filings) is a strong candidate as a catch-all for mandatory transparency disclosures that aren't explicitly earnings or management changes. However, since the content is purely about the denominator for voting rights based on the issued share capital, SHA is technically more precise regarding the subject matter (capital structure). Since this is a mandatory disclosure of the total voting rights denominator, which is a direct consequence of the capital structure, I will classify it as SHA, as it relates directly to the share capital count. If SHA is reserved strictly for *announcing* a change event (issue/split), then RNS is the fallback. Given the context of DTR 5.6.1R, these are often filed under general regulatory news. I will lean towards RNS as the most fitting general regulatory announcement category for this specific type of transparency filing that isn't a dividend, director dealing, or earnings release.
2013-02-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with "RNS Number : 8167Y" and contains the header "TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES". This form (TR-1) is used to report changes in major shareholdings, which aligns with the definition of 'Major Shareholding Notification'. The content details the acquisition/disposal of voting rights by Invesco Limited, crossing thresholds (5%, 4%). Therefore, the correct classification is MRQ (Major Shareholding Notification). Although it is distributed via RNS, the specific content dictates MRQ over the general RNS fallback.
2013-02-27 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is identified by the 'RNS Number' header, indicating it is a regulatory announcement from the London Stock Exchange's RNS service. The content explicitly details share transactions ('Director / PDMR shareholding') involving directors of Dechra Pharmaceuticals PLC. This directly matches the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is short (1823 chars), but the content is the actual transaction data, not an announcement *about* a report, thus DIRS is the correct classification over RPA or RNS.
2013-02-26 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.